Minerva Surgical, Inc.
NASDAQ:UTRS
0.0001 (USD) • At close January 13, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|
| Assets: | ||||
| Current Assets: | ||||
| Cash & Cash Equivalents
| 6.942 | 40.608 | 17.359 | 27.085 |
| Short Term Investments
| 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 6.942 | 40.608 | 17.359 | 27.085 |
| Net Receivables
| 7.244 | 7.292 | 8.379 | 3.947 |
| Inventory
| 16.85 | 15.682 | 10.201 | 4.744 |
| Other Current Assets
| 5.083 | 11.422 | 9.482 | 8.038 |
| Total Current Assets
| 36.119 | 75.004 | 45.421 | 43.814 |
| Non-Current Assets: | ||||
| Property, Plant & Equipment, Net
| 5.312 | 4.594 | 2.88 | 2.266 |
| Goodwill
| 0 | 0 | 0 | 0 |
| Intangible Assets
| 26.778 | 34.97 | 43.141 | 0 |
| Goodwill and Intangible Assets
| 26.778 | 34.97 | 43.141 | 0 |
| Long Term Investments
| 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0.691 | 0.524 | 0.604 | 0.604 |
| Total Non-Current Assets
| 32.781 | 40.088 | 46.625 | 2.87 |
| Total Assets
| 68.9 | 115.092 | 92.046 | 46.684 |
| Liabilities & Equity: | ||||
| Current Liabilities: | ||||
| Account Payables
| 2.804 | 3.629 | 3.506 | 4.193 |
| Short Term Debt
| 2.249 | 0 | 1.668 | 0 |
| Tax Payables
| 0.271 | 0.657 | 0.754 | 0.53 |
| Deferred Revenue
| 0.339 | 0.206 | 0.219 | 0.051 |
| Other Current Liabilities
| 8.615 | 17.939 | 27.12 | 10.449 |
| Total Current Liabilities
| 14.278 | 22.62 | 33.267 | 15.223 |
| Non-Current Liabilities: | ||||
| Long Term Debt
| 37.441 | 39.085 | 95.619 | 75.893 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0 | 9.283 | 184.971 | 160.092 |
| Total Non-Current Liabilities
| 37.441 | 48.368 | 280.59 | 235.985 |
| Total Liabilities
| 51.719 | 70.988 | 313.857 | 251.208 |
| Equity: | ||||
| Preferred Stock
| 0 | 115.092 | 0 | 0 |
| Common Stock
| 0.029 | 0.028 | 0.001 | 0.001 |
| Retained Earnings
| -283.668 | -249.556 | -228.092 | -209.829 |
| Accumulated Other Comprehensive Income/Loss
| 0.011 | 0.011 | 0.011 | 0.011 |
| Other Total Stockholders Equity
| 300.809 | 293.621 | 6.269 | 5.293 |
| Total Shareholders Equity
| 17.181 | 44.104 | -221.811 | -204.524 |
| Total Equity
| 17.181 | 44.104 | -221.811 | -204.524 |
| Total Liabilities & Shareholders Equity
| 68.9 | 115.092 | 92.046 | 46.684 |